Literature DB >> 33441889

Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson's disease.

Gabriella Hernadi1, David Pinter2, Szilvia Anett Nagy1,3,4,5, Gergely Orsi1,2,3, Samuel Komoly2, Jozsef Janszky2,3, Norbert Kovacs2,3, Gabor Perlaki6,7,8.   

Abstract

The absence of nigral hyperintensity is a promising MR marker for Parkinson's disease (PD), but its small size imposes limitations on its routine use. Our aim was to compare Multi Echo Data Image Combination (MEDIC), segmented echo-planar imaging (EPISEG) and fluid-attenuated inversion recovery (FLAIR) sequences, as well as both magnitude (MAG) and susceptibility-weighted imaging (SWI) reconstructions of single-echo gradient echo for nigral hyperintensity imaging. Twenty-five healthy and twenty PD subjects were included. Sensitivity to motion artefacts, confidence of the radiologist in interpretation, rate of nondiagnostic scans and diagnostic accuracy were assessed. EPISEG was less motion-sensitive than MEDIC, MAG, and SWI, while FLAIR was less motion-sensitive than MAG and SWI. The reviewers were more confident when using EPISEG compared to any other techniques and MEDIC was superior to FLAIR. The proportions of nondiagnostic scans were lower for EPISEG than for other sequences. The best diagnostic performance was achieved for EPISEG (sensitivity = 65%, specificity = 96%). Using EPISEG, the absence of nigral hyperintensity in PD was associated with higher Hoehn-Yahr stage and MDS-UPDRS II + III. Nigral hyperintensity may be intact at the very early stages of PD. The promising properties of EPISEG may help the transfer of nigral hyperintensity imaging into daily clinical practice.

Entities:  

Year:  2021        PMID: 33441889      PMCID: PMC7806895          DOI: 10.1038/s41598-020-80836-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  46 in total

1.  Visualization of nigrosomes-1 in 3T MR susceptibility weighted imaging and its absence in diagnosing Parkinson's disease.

Authors:  P Gao; P-Y Zhou; G Li; G-B Zhang; P-Q Wang; J-Z Liu; F Xu; F Yang; X-X Wu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-12       Impact factor: 3.507

2.  MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease.

Authors:  Mirco Cosottini; Daniela Frosini; Ilaria Pesaresi; Mauro Costagli; Laura Biagi; Roberto Ceravolo; Ubaldo Bonuccelli; Michela Tosetti
Journal:  Radiology       Date:  2014-02-26       Impact factor: 11.105

3.  Initial diagnostic workup of parkinsonism: Dopamine transporter positron emission tomography versus susceptibility map-weighted imaging at 3T.

Authors:  Young Hee Sung; Jongho Lee; Yoonho Nam; Hyeong-Geol Shin; Young Noh; Kyung Hoon Hwang; Haejun Lee; Eung Yeop Kim
Journal:  Parkinsonism Relat Disord       Date:  2018-12-18       Impact factor: 4.891

4.  Toward Quantifying the Prevalence, Severity, and Cost Associated With Patient Motion During Clinical MR Examinations.

Authors:  Jalal B Andre; Brian W Bresnahan; Mahmud Mossa-Basha; Michael N Hoff; C Patrick Smith; Yoshimi Anzai; Wendy A Cohen
Journal:  J Am Coll Radiol       Date:  2015-05-09       Impact factor: 5.532

5.  Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.

Authors:  Eva Reiter; Christoph Mueller; Bernadette Pinter; Florian Krismer; Christoph Scherfler; Regina Esterhammer; Christian Kremser; Michael Schocke; Gregor K Wenning; Werner Poewe; Klaus Seppi
Journal:  Mov Disord       Date:  2015-03-15       Impact factor: 10.338

6.  Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores.

Authors:  Christopher G Goetz; Glenn T Stebbins; Barbara C Tilley
Journal:  Mov Disord       Date:  2012-08-06       Impact factor: 10.338

7.  Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study.

Authors:  Frederick J A Meijer; Stefan C Steens; Anouke van Rumund; Anne-Marie van Cappellen van Walsum; Benno Küsters; Rianne A J Esselink; Marcel M Verbeek; Bastiaan R Bloem; Bożena Goraj
Journal:  Pol J Radiol       Date:  2016-08-03

8.  Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease.

Authors:  Lirong Jin; Jian Wang; Changpeng Wang; Danlan Lian; Ying Zhou; Yong Zhang; Minzhi Lv; Yuanfang Li; Zhen Huang; Xiaoqin Cheng; Guoqiang Fei; Kai Liu; Mengsu Zeng; Chunjiu Zhong
Journal:  Front Neurol       Date:  2019-02-12       Impact factor: 4.003

9.  Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.

Authors:  Anna I Blazejewska; Stefan T Schwarz; Alain Pitiot; Mary C Stephenson; James Lowe; Nin Bajaj; Richard W Bowtell; Dorothee P Auer; Penny A Gowland
Journal:  Neurology       Date:  2013-07-10       Impact factor: 9.910

10.  Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomal iron imaging in Parkinson's disease).

Authors:  Stefan T Schwarz; Yue Xing; Saadnah Naidu; Jim Birchall; Rob Skelly; Alan Perkins; Jonathan Evans; Gill Sare; Antonio Martin-Bastida; Nin Bajaj; Penny Gowland; Paola Piccini; Dorothee P Auer
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.